Movement Disorders
From the Journals
Ferric carboxymaltose calms restless legs
Nearly two-thirds of patients with restless legs syndrome remained off RLS medications at 1 year after treatment.
From the Journals
Transdermal patches ease extrapyramidal symptoms in schizophrenia
Schizophrenia patients who switched from blonanserin tablets to patches showed significant reduction in extrapyramidal symptoms but not in use of...
From the Journals
Avoidant attachment style may drive mood in movement disorders
High rates of depression found in patients with functional neurological disorders associated with avoidance of close relationships.
From the Journals
Therapeutic homework adherence improves tics in Tourette’s disorder
After eight sessions of behavior therapy, overall greater homework adherence significantly predicted reduced tic severity.
Conference Coverage
Study identifies pandemic-related stressor in Parkinson’s disease
Researchers in the Netherlands identified COVID-19–related stressors for people with Parkinson’s disease and the most vulnerable subgroups.
Conference Coverage
Surge in new-onset tics in adults tied to COVID-19 stress
“All patients, including those with organic tic disorders, had a history of anxiety and also reported worsening anxiety in the setting of the...
Feature
Toward ‘superhuman cognition’: The future of brain-computer interfaces
Among the big players in this area of research is billionaire entrepreneur Elon Musk, who in 2016 founded Neuralink.
Conference Coverage
Nonmotor symptoms common in Parkinson’s
Neuropsychiatric symptoms often go unrecognized, but they are treatable, said Dr. Leslie Citrome.
From the Journals
Anxiety, inactivity linked to cognitive impairment in Parkinson’s
Individuals who became more anxious over the 5-year study also became less active in the home,” reported Dr. Jacob D. Jones and colleagues.
From the Journals
Psychotic features among older adults tied to Parkinson’s
New-onset psychosis was associated with a fivefold increased risk of both subthreshold parkinsonism and depression, Dr. Ioanna Pachi reported.
From the Journals
Increased risk of hospitalization and death with Parkinson’s drug
The use of pimavanserin, a treatment for Parkinson’s psychosis, has been tied to an increased risk of hospitalization and mortality, a new study...